...
机译:从凋亡骨骼细胞中释放CXCL12有助于在大鼠的地塞米松治疗后的骨生长缺陷
Univ South Australia Sch Pharm &
Med Sci Bldg HB City West Campus North Terrace Adelaide SA;
Univ South Australia Sch Pharm &
Med Sci Bldg HB City West Campus North Terrace Adelaide SA;
Univ South Australia Sch Pharm &
Med Sci Bldg HB City West Campus North Terrace Adelaide SA;
Univ South Australia Sch Pharm &
Med Sci Bldg HB City West Campus North Terrace Adelaide SA;
Univ South Australia Sch Pharm &
Med Sci Bldg HB City West Campus North Terrace Adelaide SA;
Univ South Australia Sch Pharm &
Med Sci Bldg HB City West Campus North Terrace Adelaide SA;
Univ South Australia Sch Pharm &
Med Sci Bldg HB City West Campus North Terrace Adelaide SA;
MOLECULAR PATHWAYS-DEVELOPMENT; BONE LOSS; OSTEOCYTES; GROWTH PLATE; PRECLINICAL STUDIES;
机译:从凋亡骨骼细胞中释放CXCL12有助于在大鼠的地塞米松治疗后的骨生长缺陷
机译:基于细胞的植入治疗植入的人骨髓源性单核细胞改善了大鼠大骨缺损的骨愈合
机译:从工作台到诊所再到背部:骨骼干细胞和撞击式植骨术可再生骨缺损。
机译:施用控制释放的碱性纤维细胞生长因子 - 这是比骨髓细胞移植的更有效的血管生成治疗,这是严重的缺血性的心吗?
机译:地塞米松刺激成年大鼠骨细胞群中骨祖细胞分化的部分原因是通过增加对胰岛素样生长因子的反应。
机译:生长激素释放因子:两种类似物的比较并证明放疗后下丘脑生长激素释放的缺陷。
机译:从凋亡骨骼细胞中释放CXCL12有助于在大鼠的地塞米松治疗后的骨生长缺陷